Embla Medical, a leading name in the medical technology sector, is headquartered in Iceland (IS) and operates extensively across Europe and North America. Founded in 1998, the company has established itself as a pioneer in sleep diagnostics and respiratory care, offering innovative solutions that enhance patient outcomes.
Embla Medical's core products include advanced sleep monitoring devices and software, which are distinguished by their accuracy and user-friendly design. The company has achieved significant milestones, including the development of cutting-edge polysomnography systems that cater to both clinical and home settings.
With a strong market position, Embla Medical is recognised for its commitment to quality and innovation, making it a trusted partner for healthcare professionals worldwide.
+49 vs industry average
Embla Medical’s score of 71 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Embla Medical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Embla Medical's reported carbon emissions
In 2025, Embla Medical hf reported total carbon emissions of approximately 221.8 million kg CO2e. This figure includes Scope 1 emissions of about 15.9 million kg CO2e, Scope 2 emissions of approximately 10.9 million kg CO2e, and Scope 3 emissions of around 293.4 million kg CO2e. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its value chain by 2050. Embla Medical has established near-term targets to reduce absolute Scope 1 and 2 emissions by 79% by 2030 from a 2019 baseline, and to cut Scope 3 emissions by 25% by 2030 from a 2021 baseline. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions by 2050, as well as a 90% reduction in Scope 3 emissions by the same year. These targets align with the Science Based Targets initiative (SBTi) and reflect the company's commitment to sustainable practices within the healthcare equipment and supplies sector. Embla Medical's headquarters is located in Iceland, and it is part of a corporate family that includes Össur hf., which shares similar climate commitments and targets.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Embla Medical’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Embla Medical yet.
Scope 3 top emissions categories
11 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Embla Medical
Frequently asked questions
Common questions about Embla Medical’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project